Cellectar Biosciences, Inc.
corporate_fare Company Profile
Cellectar Biosciences, Inc. (NASDAQ:CLRB) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 22 items for CLRB at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Cellectar Biosciences Discloses Going Concern Doubt, Financial Restatement, and Heavy Dilution Amidst Clinical Progress
- Cellectar Biosciences Reports $8.35 Loss Per Share for 2025
Financial Snapshot
Fiscal year ended December 31, 2025
Net Income
-$21.79M
Diluted EPS
-$8.35
Op. Cash Flow
-$23.12M
Free Cash Flow
-$23.12M
Operating Income
-$22.98M
Cash & Equivalents
$13.2M
Debt / Equity
0.00×
Shares Outstanding
4.24M sh
Source: 10-K · filed 2026-04-30 · accession 0001104659-26-053090
show_chartPrice Chart
Loading chart...